New eye drop BUFY01 takes on SVS20 in dry eye showdown
NCT ID NCT05865379
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 33 times
Summary
This study tests if a new eye drop, BUFY01, works as well as an existing one, SVS20, for treating dry eye disease. About 80 adults with dry eyes will use one of the two drops daily for three months. Researchers will check eye health and symptoms to see if both treatments provide similar relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Saint-Etienne
RECRUITINGSaint-Priest-en-Jarez, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital des Quinze-Vingts
RECRUITINGParis, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.